Transforming Growth Factor Alpha (TGF-) and Other Targets of Tumor Necrosis Factor-Alpha Converting Enzyme (TACE) in Murine Polycystic Kidney Disease

Pediatric Research

Volumn 57, Issue 5, 2005, Pages 732-737

  Nemo, Raghad ^a   Murcia, Noel ^a   Dell, Katherine Macrae ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENOTYPE; HETEROZYGOTE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY MASS; KIDNEY POLYCYSTIC DISEASE; LIVER; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

ADAM PROTEINS; ALLELES; ANIMALS; BLOOD UREA NITROGEN; BODY WEIGHT; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; GENES, RECESSIVE; GENOTYPE; GLYCOPROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY DISEASES, CYSTIC; LIVER; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; MUTATION; ORGAN SIZE; PHENOTYPE; POLYCYSTIC KIDNEY DISEASES; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 17744398648     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/01.PDR.0000159513.51898.60     Document Type: Article

References (41)

1. Dell KM, Avner ED 2003 Polycystic kidney disease. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric Nephrology. Lippincott, Williams & Wilkins, Philadelphia, pp 675-699.
2. Dell KM, Nemo R, Sweeney WE Jr, Levin JI, Frost P, Avner ED 2001 A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease. Kidney Int 60:1240-1248.
3. Lee DC, Chan KW, Chan SY 1998 Expression of transforming growth factor alpha and epidermal growth factor receptor in adult polycystic kidney disease. J Urol 159:291-296.
4. Klingel R, Dippold W, Storkel S, Meyerzum Buschenfelde KH, Kohler H 1992 Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma. Am J Kidney Dis 19:22-30.
5. Lowden DA, Lindemann GW, Merlino G, Barash BD, Calvet JP, Gattone VH II 1994 Renal cysts in transgenic mice expressing transforming growth factor-alpha. J Lab Clin Med 124:386-394.
6. Gattone VH II, Kuenstler KA, Lindemann GW, Lu X, Cowley BD Jr, Rankin CA, Calvet JP 1996 Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse. J Lab Clin Med 127:214-222.
7. Sweeney WE, Chen Y, Nakanishi K, Frost P, Avner ED 2000 Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int 57:33-40.
8. Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, Frost P, Avner ED 2003 EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int 64:1573-1579.
9. Sweeney WE Jr, Hamahira K, Sweeney J, Garcia-Gatrell M, Frost P, Avner ED 2003 Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. Kidney Int 64:1310-1319.
10. Cogswell C, Price SJ, Hou X, Guay-Woodford LM, Flaherty L, Bryda EC 2003 Positional cloning of jcpk/bpk locus of the mouse. Mamm Genome 14:242-249.
11. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AR 1993 Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73:249-261.
12. Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC 1993 TGF-α deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73:263-278.
13. Nauta J, Ozawa Y, Sweeney WE Jr, Rutledge JC, Avner ED 1993 Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease. Pediatr Nephrol 7:163-172.
14. Nakanishi K, Sweeney WE Jr, Zerres K, Guay-Woodford LM, Avner ED 2000 Proximal tubular cysts in fetal human autosomal recessive polycystic kidney disease. J Am Soc Nephrol 11:760-763.
15. MacRae Dell K, Nemo R, Sweeney WE Jr, Avner ED 2004 EGF-related growth factors in the pathogenesis of murine ARPKD. Kidney Int 65:2018-2029.
16. Lakshmanan J, Eysselein V 1993 Hereditary error in epidermal growth factor prohormone metabolism in a rat model of autosomal dominant polycystic kidney disease. Biochem Biophys Res Commun 197:1083-1093.
17. Lakshmanan J, Fisher DA 1993 An inborn error in epidermal growth factor prohormone metabolism in a mouse model of autosomal recessive polycystic kidney disease. Biochem Biophys Res Commun 196:892-901.
18. Moskowitz DW, Bonar SL, Liu W, Sirgi CF, Marcus MD, Clayman RV 1995 Epidermal growth factor precursor is present in a variety of human renal cyst fluids. J Urol 153:578-583.
19. Munemura C, Uemasu J, Kawasaki H 1994 Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: possible evidence of heterogeneity in cystogenesis. Am J Kidney Dis 24:561-568.
20. Gattone VH Jr, Andrews GK, Niu FW, Chadwick LJ, Klein RM, Calvet JP 1990 Defective epidermal growth factor gene expression in mice with polycystic kidney disease. Dev Biol 138:225-230.
21. Orellana SA, Sweeney WE, Neff CD, Avner ED 1995 Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int 47:490-499.
22. Sheflin LG, Brooks EM, Keegan BP, Spaulding SW 1996 The cytosolic 47-kilodalton protein that binds to the 3′ untranslated region of epidermal growth factor transcripts responds to orchiectomy in a tissue-specific fashion. Endocrinology 137:5616-5623.
23. Mroczkowski B, Reich M, Chen K, Bell GI, Cohen S 1989 Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity. Mol Cell Biol 9:2771-2778.
24. Luetteke NC, Qui TH, Fenton SE, Troyer KL, Riedel RF, Chang A, Lee DC 1999 Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126:2739-2750.
25. Means AL, Ray KC, Singh AB, Washington MK, Whitehead RH, Harris RC Jr, Wright CV, Coffey RJ Jr, Leach SD 2003 Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. Gastroenterology 124:1020-1036.
26. Wagner M, Weber CK, Bressau F, Greten FR, Stagge V, Ebert M, Leach SD, Adler G, Schmid RM 2002 Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells. Gastroenterology 122:1898-1912.
27. Brandt R, Eisenbrandt R, Leenders F, Zschiesche W, Binas B, Juergensen C, Theuring F 2000 Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation. Oncogene 19:2129-2137.
28. Wong RW, Kwan RW, Mak PH, Mak KK, Sham MH, Chan SY 2000 Overexpression of epidermal growth factor induced hypospermatogenesis in transgenic mice. J Biol Chem 275:18297-18301.
29. Madtes DK, Elston AL, Hackman RC, Dunn AR, Clark JG 1999 Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice. Am J Respir Cell Mol Biol 20:924-934.
30. Cook GA, Yeomans ND, Giraud AS 1997 Temporal expression of trefoil peptides in the TGF-alpha knockout mouse after gastric ulceration. Am J Physiol 272:G1540-G1549.
31. Xian CJ, Li L, Deng YS, Zhao SP, Zhou XF 2001 Lack of effects of transforming growth factor-alpha gene knockout on peripheral nerve regeneration may result from compensatory mechanisms. Exp Neurol 172:182-188.
32. Olbrich H, Fliegauf M, Hoefele J, Kispert A, Otto E, Volz A, Wolf MT, Sasmaz G, Trauer U, Reinhardt R, Sudbrak R, Antignac C, Gretz N, Walz G, Schermer B, Benzing T, Hildebrandt F, Omran H 2003 Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapato-retinal degeneration and hepatic fibrosis. Nat Genet 34:455-459.
33. Nakanishi K, Gattone VH II, Sweeney WE, Avner ED 2001 Renal dysfunction but not cystic change is ameliorated by neonatal epidermal growth factor in bpk mice. Pediatr Nephrol 16:45-50.
34. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA 1998 An essential role for ectodomain shedding in mammalian development. Science 282:1281-1284.
35. Harris RC, Chung E, Coffey RJ 2003 EGF receptor ligands. Exp Cell Res 284:2-13.
36. Derynck R 1992 The physiology of transforming growth factor-α. Adv Cancer Res 58:27-52.
37. Gschwind A, Hart S, Fischer OM, Ullrich A 2003 TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J 22:2411-2421.
38. Hinkle CL, Sunnarborg SW, Loiselle D, Parker CE, Stevenson M, Russell WE, Lee DC 2004 Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J Biol Chem 279:24179-24188.
39. Rio C, Buxbaum JD, Peschon JJ, Corfas G 2000 Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. J Biol Chem 275:10379-10387.
40. Rankin CA, Suzuki K, Itoh Y, Ziemer DM, Grantham JJ, Calvet JP, Nagase H 1996 Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules. Kidney Int 50:835-844.
41. Sweeney WE Jr, Kusner L, Carlin CR, Chang S, Futey L, Cotton CU, Dell KM, Avner ED 2001 Phenotypic analysis of conditionally immortalized cells isolated from the BPK model of ARPKD. Am J Physiol Cell Physiol 281:C1695-C1705.